会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • GASTRIN RELEASING PEPTIDE COMPOUNDS
    • GASTRIN释放肽化合物
    • WO2009143101A3
    • 2010-01-14
    • PCT/US2009044447
    • 2009-05-19
    • BRACCO IMAGING SPALATTUADA LUCIANOCAPPELLETTI ENRICOLINDER KAREN ENUNN ADRIAN DLANTRY LAURA
    • LATTUADA LUCIANOCAPPELLETTI ENRICOLINDER KAREN ENUNN ADRIAN DLANTRY LAURA
    • A01N37/18A61K38/00
    • A61K51/088A61K49/0056G01N33/57492G01N2333/5758
    • Methods and compositions for diagnosing, staging disease, monitoring therapeutic effect of drugs and imaging a patient are provided, including radiopharmaceutical formulations. Compositions comprising Ga-AMBA complexed with a radioactive isotope are provided; as are methods of imaging Gastrin Releasing Peptide receptor (GRP-R) bearing tissue and methods of diagnosing or staging disease in patients suspected of having disease associated with aberrant GRP-R function. Further, methods of monitoring therapeutic effect of a drug targeted to a receptor that crosstalks with GRP-R are provided; as are methods of pre-dosing/co-dosing non-target tissues containing GRP-R. Particularly, methods of monitoring activity of receptors and receptor pathways in vivo/in vitro by using a ligand that binds to the GRP-R are provided; as are methods of measuring the activity of a receptor or group of receptors and their associated pathways that exhibit crosstalk with the GRP-R by using such a ligand which is also detectable by external means.
    • 提供用于诊断,分期疾病,监测药物的治疗效果和成像患者的方法和组合物,包括放射性药物制剂。 提供了包含与放射性同位素复合的Ga-AMBA的组合物; 成像胃泌素释放肽受体(GRP-R)携带组织的成像方法以及疑似与异常GRP-R功能相关疾病的患者诊断或分期疾病的方法。 此外,提供监测靶向与GRP-R串扰的受体的药物的治疗效果的方法; 预先给药/共同给予含有GRP-R的非靶组织的方法也是如此。 特别地,提供了通过使用与GRP-R结合的配体来体内/体外监测受体和受体途径的活性的方法; 以及通过使用也可以通过外部手段检测的这种配体来测量与GRP-R显示串扰的受体或受体组及其相关途径的活性的方法。
    • 10. 发明专利
    • NO328627B1
    • 2010-04-12
    • NO20032440
    • 2003-05-28
    • BRACCO IMAGING SPA
    • ANELLI PIER LUCIOBROCCHETTA MARINOLUX GIOVANNACAPPELLETTI ENRICO
    • A61K49/04C07C237/46C07B51/00C07C231/02C07C231/12C07D319/06
    • A process for the preparation of ( S)-N,N' -bis[2-hydroxy-1 (hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4,6-triiodo-1,3-benzenedicarboxamide (iopamidol) starting from 5-amino- N,N' -bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-1,3-benzenedicarboxamide (II) which process comprises a) reacting the compound of formula (II) with a suitable protecting agent, to give a compound of formula (III) wherein -R is a group of formula A or B wherein R 1 is a hydrogen atom, a C 1 -C 4 straight or branched alkyl group or a C 1 -C 4 straight or branched alkoxy group, R 2 is hydrogen, a C 1 -C 4 straight or branched alkyl group or a C 1 -C 4 straight or branched alkoxy group and R 3 is a C 1 -C 4 straight or branched alkyl group, a trifluoromethyl or a trichloromethyl group; b) acylating the amino group in position 5 of the intermediate compound of formula (III), by reaction with a (S) -2-(acetyloxy)propanoyl chloride to give a compound of formula (IV) wherein R is defined above; and c) removing all the acyl groups present in the compound of formula (IV) under basic conditions, with prior cleavage of the cyclic protections of the hydroxy groups in the carboxamido substituents under acidic conditions, when R is a group of formula A carboxamido hydroxy groups under acidic conditions.